Investor Overview

Webcast ImageWebcast
Verastem Inc at the Deutsche Bank 40th Annual Healthcare Conference  (Live)
05/06/15 at 3:30 p.m. ET
Verastem Inc at the Deutsche Bank 40th Annual Healthcare Conference
Wednesday, May 6, 2015 3:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Verastem, Inc. (NASDAQ: VSTM) is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt.
Stock Quote
VSTM (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.53
Change (%) Stock is Up 0.23 (2.77%)
Volume703,402
Data as of 05/01/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News More >>
DateTitle 
04/30/15Verastem to Present at Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--Apr. 30, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will participate at the following upcoming investor conferences: Deutsche Bank 40th Annual Healthcare Conference on Wednesday, May 6, 2015 at 3:30 p.m. ET at the InterContinental Hotel in Boston Mizuho S... 
Printer Friendly Version
04/22/15Verastem Presents Encouraging Scientific Data on the Preferential Targeting of Cancer Stem Cells at the 2015 American Association of Cancer Research Annual Meeting
BOSTON--(BUSINESS WIRE)--Apr. 22, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the presentation of scientific data at the 2015 American Association of Cancer Research (AACR) Annual Meeting being held April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia, PA. “The scientific research presented by both Verastem and our... 
Printer Friendly Version
03/19/15Verastem to Present Data at the 2015 American Association of Cancer Research Annual Meeting
BOSTON--(BUSINESS WIRE)--Mar. 19, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced data presentations at the 2015 American Association of Cancer Research (AACR) Annual Meeting being held April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia, PA. The details for the data presentations at AACR are as follows: ... 
Printer Friendly Version
03/10/15Verastem Reports Year-End 2014 Financial Results
— COMMAND Interim Analysis Expected Second Quarter 2015 — BOSTON--(BUSINESS WIRE)--Mar. 10, 2015-- Verastem, Inc., (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the year ended December 31, 2014, and also commented on corporate accomplishments and plans. "COMMAND enrollment remains on track and we continue to anticipate condu... 
Printer Friendly Version
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Verastem Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.